MarketPulse

preclinical results

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Fibrobiologics, Inc.

FibroBiologics Advances Clinical Pipeline With cGMP Manufacturing, Raises $3M

FibroBiologics completes cGMP manufacturing for lead candidate CYWC628, expects first patient dosing Q2 2026 in diabetic foot ulcer trial. Company raises $3M and maintains $1.5M cash.
FBLGcapital raisepreclinical results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Atea's AT-587 Shows Promise as Potential First HEV Treatment in Preclinical Study

Atea's AT-587 shows promise as first potential HEV treatment, demonstrating 30-150x greater antiviral activity than existing agents in preclinical studies. Phase 1 trials expected mid-2026.
AVIRPhase 1 clinical trialHepatitis E Virus